Directory
>
David Hallal
David Hallal
Executive Chairman | iTeos Therapeutics
Boston, Massachusetts, United States
David Hallal
Summary
David Hallal is an accomplished executive with extensive experience in the biotechnology and pharmaceutical sectors. As the CEO, Chair, and Co-Founder of ElevateBio, he leads innovative initiatives that aim to transform the landscape of cell and gene therapies. His strategic vision and leadership have been instrumental in the success of several organizations, including Allovir and Iteos Therapeutics, where he serves as Executive Chairman and Chairman of the Board, respectively. David's career spans over three decades, during which he has held multiple senior leadership roles at prominent companies such as Alexion Pharmaceuticals and Amgen. He is known for his ability to drive growth and operational excellence in competitive markets. Beyond his corporate endeavors, David is passionate about fostering innovation and advancing healthcare solutions. His commitment to leadership development and mentorship is evident in his board memberships and advisory roles across various organizations.
David Hallal
Work Experience
Executive Chairman at
AlloVir
September 2018 - Present
Chairman, Board of Directors at
iTeos Therapeutics
June 2018 - Present
Member Board Of Directors at
Seer
February 2018 - Present
CEO, Chair, and Co-Founder at
ElevateBio
December 2017 - Present
Chairman, Board of Directors at
Scholar Rock
July 2017 - Present
Chief Executive Officer at
Alexion Pharmaceuticals, Inc.
April 2015 - December 2016
Chief Operating Officer at
Alexion Pharmaceuticals, Inc.
September 2014 - April 2015
Chief Commercial Officer, Head of Commercial Operations at
Alexion Pharmaceuticals, Inc.
July 2006 - September 2014
Vice President of Sales at
Eyetech Pharmaceuticals
April 2004 - June 2006
National Sales Director at
Biogen
August 2002 - March 2004
Multiple Commercial Leadership Roles at
Amgen, Inc.
February 1992 - August 2002
Sales Representative at
The Upjohn
September 1988 - February 1992
Frequently Asked Questions about David Hallal
What is David Hallal email address?
David Hallal's primary email address is *******@elevate.bio. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does David Hallal work for?
David Hallal is a Executive Chairman at iTeos Therapeutics, a company specializing in Commercial physical research.
How can I directly contact David Hallal?
To contact David Hallal directly, you can use the email address *******@elevate.bio. Complete contact information is available upon registration with Muraena.
Who is David Hallal?
David Hallal is an accomplished executive with extensive experience in the biotechnology and pharmaceutical sectors. As the CEO, Chair, and Co-Founder of ElevateBio, he leads innovative initiatives that aim to transform the landscape of cell and gene therapies. His strategic vision and leadership have been instrumental in the success of several organizations, including Allovir and Iteos Therapeutics, where he serves as Executive Chairman and Chairman of the Board, respectively. David's career spans over three decades, during which he has held multiple senior leadership roles at prominent companies such as Alexion Pharmaceuticals and Amgen. He is known for his ability to drive growth and operational excellence in competitive markets. Beyond his corporate endeavors, David is passionate about fostering innovation and advancing healthcare solutions. His commitment to leadership development and mentorship is evident in his board memberships and advisory roles across various organizations.
David`s contact details
*******@elevate.bio
*******@seer.bio
*******@allovir.com
************@iteostherapeutics.com
Colleagues
VP, Global Head of CMC
Executive Vice President, Head of Legal and Corporate Secretary
Executive Vice President Human Resources
VP Project Head
Chair Of The Board Of Directors
Chief Accountant
VP, Medical Affairs
Vice President Clinical Development
Vice President, Regulatory Affairs
Vice President & Head of Project Management